|
2008
|
IC50 |
|
Inhibition of MRP1 expressed in human 2008 cells assessed as calcein AM accumulation by cell based assay
Inhibition of MRP1 expressed in human 2008 cells assessed as calcein AM accumulation by cell based assay
|
[PMID: 21354800]
|
|
2008
|
IC50 |
|
Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
2008
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
2008
|
IC50 |
|
Inhibition of MRP1 expressed in human 2008 cells assessed as calcein AM accumulation by cell based assay
Inhibition of MRP1 expressed in human 2008 cells assessed as calcein AM accumulation by cell based assay
|
[PMID: 21354800]
|
|
2008
|
IC50 |
|
Inhibition of MRP1 expressed in human 2008 cells assessed as calcein AM accumulation by cell based assay
Inhibition of MRP1 expressed in human 2008 cells assessed as calcein AM accumulation by cell based assay
|
[PMID: 21354800]
|
|
2008
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A2780 ADR
|
IC50 |
|
Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay
Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay
|
[PMID: 21354800]
|
|
A2780 ADR
|
IC50 |
|
Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay
Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay
|
[PMID: 21354800]
|
|
A-375
|
IC50 |
69.72 3
Compound: 3, Pque
|
Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-375
|
IC50 |
69.72 3
Compound: 3, Pque
|
Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-431
|
IC50 |
82.25 3
Compound: 3, Pque
|
Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-431
|
IC50 |
57.54 3
Compound: 3, Pque
|
Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-431
|
IC50 |
57.54 3
Compound: 3, Pque
|
Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-431
|
IC50 |
82.25 3
Compound: 3, Pque
|
Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A549
|
IC50 |
|
Anticancer activity against human A549 cells by HTS assay
Anticancer activity against human A549 cells by HTS assay
|
[PMID: 25139569]
|
|
A-375
|
IC50 |
69.72 3
Compound: 3, Pque
|
Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A549
|
IC50 |
|
Anticancer activity against human A549 cells by HTS assay
Anticancer activity against human A549 cells by HTS assay
|
[PMID: 25139569]
|
|
BXPC-3
|
IC50 |
|
Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-431
|
IC50 |
57.54 3
Compound: 3, Pque
|
Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
BXPC-3
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
C13
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
C13
|
IC50 |
|
Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A-431
|
IC50 |
82.25 3
Compound: 3, Pque
|
Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
Calu-1
|
IC50 |
|
Anticancer activity against human Calu1 cells by HTS assay
Anticancer activity against human Calu1 cells by HTS assay
|
[PMID: 25139569]
|
|
A2780 ADR
|
IC50 |
|
Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay
Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay
|
[PMID: 21354800]
|
|
Calu-1
|
IC50 |
|
Anticancer activity against human Calu1 cells by HTS assay
Anticancer activity against human Calu1 cells by HTS assay
|
[PMID: 25139569]
|
|
HCT-15
|
IC50 |
68.11 3
Compound: 3, Pque
|
Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
HCT-15
|
IC50 |
68.11 3
Compound: 3, Pque
|
Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
A549
|
IC50 |
|
Anticancer activity against human A549 cells by HTS assay
Anticancer activity against human A549 cells by HTS assay
|
[PMID: 25139569]
|
|
HEK293
|
IC50 |
141.87 3
Compound: 3, Pque
|
Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
BXPC-3
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
HEK293
|
IC50 |
141.87 3
Compound: 3, Pque
|
Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
C13
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
HeLa
|
IC50 |
|
Anticancer activity against human HeLa cells by HTS assay
Anticancer activity against human HeLa cells by HTS assay
|
[PMID: 25139569]
|
|
HeLa
|
IC50 |
|
Anticancer activity against human HeLa cells by HTS assay
Anticancer activity against human HeLa cells by HTS assay
|
[PMID: 25139569]
|
|
HL-60
|
IC50 |
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 25014747]
|
|
HL-60
|
IC50 |
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 25014747]
|
|
Calu-1
|
IC50 |
|
Anticancer activity against human Calu1 cells by HTS assay
Anticancer activity against human Calu1 cells by HTS assay
|
[PMID: 25139569]
|
|
HOP-62
|
IC50 |
|
Anticancer activity against human HOP62 cells by HTS assay
Anticancer activity against human HOP62 cells by HTS assay
|
[PMID: 25139569]
|
|
HOP-62
|
IC50 |
|
Anticancer activity against human HOP62 cells by HTS assay
Anticancer activity against human HOP62 cells by HTS assay
|
[PMID: 25139569]
|
|
HCT-15
|
IC50 |
68.11 3
Compound: 3, Pque
|
Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
KB
|
ED50 |
|
Cytotoxicity against human KB cells after 72 hrs
Cytotoxicity against human KB cells after 72 hrs
|
[PMID: 1955888]
|
|
HEK293
|
IC50 |
141.87 3
Compound: 3, Pque
|
Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
KB
|
ED50 |
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 469554]
|
|
L929
|
IC50 |
> 100 3
Compound: 9, 3,7,3',4'-tetra-O-methylated quercetin
|
Cytotoxicity against mouse L929 cells after 5 days by MTS assay
Cytotoxicity against mouse L929 cells after 5 days by MTS assay
|
[PMID: 22743241]
|
|
KB
|
ED50 |
|
Cytotoxicity against human KB cells after 72 hrs
Cytotoxicity against human KB cells after 72 hrs
|
[PMID: 1955888]
|
|
HL-60
|
IC50 |
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 25014747]
|
|
L929
|
IC50 |
>100 3
Compound: 9, 3,7,3',4'-tetra-O-methylated quercetin
|
Cytotoxicity against mouse L929 cells after 5 days by MTS assay
Cytotoxicity against mouse L929 cells after 5 days by MTS assay
|
[PMID: 22743241]
|
|
HOP-62
|
IC50 |
|
Anticancer activity against human HOP62 cells by HTS assay
Anticancer activity against human HOP62 cells by HTS assay
|
[PMID: 25139569]
|
|
LOX IMVI
|
IC50 |
|
Anticancer activity against human LOXIMVI cells by HTS assay
Anticancer activity against human LOXIMVI cells by HTS assay
|
[PMID: 25139569]
|
|
LOX IMVI
|
IC50 |
|
Anticancer activity against human LOXIMVI cells by HTS assay
Anticancer activity against human LOXIMVI cells by HTS assay
|
[PMID: 25139569]
|
|
HeLa
|
IC50 |
|
Anticancer activity against human HeLa cells by HTS assay
Anticancer activity against human HeLa cells by HTS assay
|
[PMID: 25139569]
|
|
M14
|
IC50 |
|
Anticancer activity against human M14 cells by HTS assay
Anticancer activity against human M14 cells by HTS assay
|
[PMID: 25139569]
|
|
MCF7
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
M14
|
IC50 |
|
Anticancer activity against human M14 cells by HTS assay
Anticancer activity against human M14 cells by HTS assay
|
[PMID: 25139569]
|
|
KB
|
ED50 |
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 469554]
|
|
MCF7
|
IC50 |
|
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
KB
|
ED50 |
|
Cytotoxicity against human KB cells after 72 hrs
Cytotoxicity against human KB cells after 72 hrs
|
[PMID: 1955888]
|
|
MDCK
|
IC50 |
|
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
MCF7
|
IC50 |
|
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
L929
|
IC50 |
> 100 3
Compound: 9, 3,7,3',4'-tetra-O-methylated quercetin
|
Cytotoxicity against mouse L929 cells after 5 days by MTS assay
Cytotoxicity against mouse L929 cells after 5 days by MTS assay
|
[PMID: 22743241]
|
|
MDCK
|
IC50 |
|
Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry
Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry
|
[PMID: 21354800]
|
|
MDCK
|
IC50 |
|
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
LOX IMVI
|
IC50 |
|
Anticancer activity against human LOXIMVI cells by HTS assay
Anticancer activity against human LOXIMVI cells by HTS assay
|
[PMID: 25139569]
|
|
MDCK-II
|
IC50 |
|
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay
|
[PMID: 23851114]
|
|
MDCK
|
IC50 |
|
Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry
Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry
|
[PMID: 21354800]
|
|
M14
|
IC50 |
|
Anticancer activity against human M14 cells by HTS assay
Anticancer activity against human M14 cells by HTS assay
|
[PMID: 25139569]
|
|
MDCK-II
|
IC50 |
|
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of pheophorbide-A preincubated for 30 mins before pheophorbide-A addition measured after 120 mins by flow cytometry
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of pheophorbide-A preincubated for 30 mins before pheophorbide-A addition measured after 120 mins by flow cytometry
|
[PMID: 23851114]
|
|
MDCK-II
|
IC50 |
|
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay
|
[PMID: 23851114]
|
|
MCF7
|
IC50 |
|
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
NCI/ADR-RES
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
MDCK-II
|
IC50 |
|
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of pheophorbide-A preincubated for 30 mins before pheophorbide-A addition measured after 120 mins by flow cytometry
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of pheophorbide-A preincubated for 30 mins before pheophorbide-A addition measured after 120 mins by flow cytometry
|
[PMID: 23851114]
|
|
MCF7
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
NCI/ADR-RES
|
IC50 |
|
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
MDCK
|
IC50 |
|
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
NCI-H1299
|
IC50 |
|
Anticancer activity against human H1299 cells by HTS assay
Anticancer activity against human H1299 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H1299
|
IC50 |
|
Anticancer activity against human H1299 cells by HTS assay
Anticancer activity against human H1299 cells by HTS assay
|
[PMID: 25139569]
|
|
MDCK
|
IC50 |
|
Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry
Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry
|
[PMID: 21354800]
|
|
NCI-H157
|
IC50 |
|
Anticancer activity against human NCI-H157 cells by HTS assay
Anticancer activity against human NCI-H157 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H157
|
IC50 |
|
Anticancer activity against human NCI-H157 cells by HTS assay
Anticancer activity against human NCI-H157 cells by HTS assay
|
[PMID: 25139569]
|
|
MDCK-II
|
IC50 |
|
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay
|
[PMID: 23851114]
|
|
NCI-H1792
|
IC50 |
|
Anticancer activity against human NCI-H1792 cells by HTS assay
Anticancer activity against human NCI-H1792 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H1944
|
IC50 |
|
Anticancer activity against human NCI-H1944 cells by HTS assay
Anticancer activity against human NCI-H1944 cells by HTS assay
|
[PMID: 25139569]
|
|
MDCK-II
|
IC50 |
|
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of pheophorbide-A preincubated for 30 mins before pheophorbide-A addition measured after 120 mins by flow cytometry
Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of pheophorbide-A preincubated for 30 mins before pheophorbide-A addition measured after 120 mins by flow cytometry
|
[PMID: 23851114]
|
|
NCI-H1792
|
IC50 |
|
Anticancer activity against human NCI-H1792 cells by HTS assay
Anticancer activity against human NCI-H1792 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H1944
|
IC50 |
|
Anticancer activity against human NCI-H1944 cells by HTS assay
Anticancer activity against human NCI-H1944 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H1299
|
IC50 |
|
Anticancer activity against human H1299 cells by HTS assay
Anticancer activity against human H1299 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H460
|
IC50 |
|
Anticancer activity against human H460 cells by HTS assay
Anticancer activity against human H460 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H157
|
IC50 |
|
Anticancer activity against human NCI-H157 cells by HTS assay
Anticancer activity against human NCI-H157 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H460
|
IC50 |
|
Anticancer activity against human H460 cells by HTS assay
Anticancer activity against human H460 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H522
|
IC50 |
|
Anticancer activity against human NCI-H522 cells by HTS assay
Anticancer activity against human NCI-H522 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H522
|
IC50 |
|
Anticancer activity against human NCI-H522 cells by HTS assay
Anticancer activity against human NCI-H522 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H1792
|
IC50 |
|
Anticancer activity against human NCI-H1792 cells by HTS assay
Anticancer activity against human NCI-H1792 cells by HTS assay
|
[PMID: 25139569]
|
|
Neutrophil
|
IC50 |
|
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release
|
[PMID: 18163582]
|
|
NCI-H1944
|
IC50 |
|
Anticancer activity against human NCI-H1944 cells by HTS assay
Anticancer activity against human NCI-H1944 cells by HTS assay
|
[PMID: 25139569]
|
|
Neutrophil
|
IC50 |
|
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation
|
[PMID: 18163582]
|
|
NCI-H460
|
IC50 |
|
Anticancer activity against human H460 cells by HTS assay
Anticancer activity against human H460 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI-H522
|
IC50 |
|
Anticancer activity against human NCI-H522 cells by HTS assay
Anticancer activity against human NCI-H522 cells by HTS assay
|
[PMID: 25139569]
|
|
NCI/ADR-RES
|
IC50 |
> 100 3
Compound: 3, Pque
|
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 25906385]
|
|
Neutrophil
|
IC50 |
|
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation
|
[PMID: 18163582]
|
|
Neutrophil
|
IC50 |
|
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release
Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release
|
[PMID: 18163582]
|